Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

1.900 +0.790 (+71.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,646,607
Open 1.360
Bid (Size) 2.120 (5)
Ask (Size) 2.150 (91)
Prev. Close 1.110
Today's Range 1.090 - 2.370
52wk Range 0.2500 - 4.330
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19

Performance

YTD
+413.51%
+413.51%
1 Month
+16.56%
+16.56%
3 Month
-5.47%
-5.47%
6 Month
+480.86%
+480.86%
1 Year
+208.94%
+208.94%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
GeoVax to Present at BIO International Convention 2024
Via TheNewswire.com
Exposures COVID-19
GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress
Via NewMediaWire
Exposures COVID-19
GeoVax Labs, Inc. (NASDAQ: GOVX) Featured in Coverage of the 36th Annual Roth Conference
Via Investor Brand Network
Exposures COVID-19
GeoVax to Present at BIO International Convention 2024
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Via NewMediaWire
Geovax Labs: Q4 Earnings Insights
Via Benzinga
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
GOVX Stock Earnings: Geovax Labs Beats EPS for Q1 2024
Via InvestorPlace
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Via TheNewswire.com
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Via NewMediaWire
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
Via NewMediaWire
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
Via TheNewswire.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
Via NewMediaWire
Exposures COVID-19
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
Via TheNewswire.com
Exposures COVID-19
GeoVax to Present at the 36th Annual Roth Conference
Via NewMediaWire
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
Via NewMediaWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.